Passerini L, Barzaghi F, Curto R, Sartirana C, Barera G, Tucci F, Albarello L, Mariani A, Testoni PA, Bazzigaluppi E, Bosi E, Lampasona V, Neth O, Zama D, Hoenig M, Schulz A, Seidel MG, Rabbone I, Olek S, Roncarolo MG, Cicalese MP, Aiuti A, Bacchetta R. Treatment with rapamycin can restore regulatory T-cell function in IPEX patients. J Allergy Clin Immunol. 2020;145(4):1262-1271.e13. https://doi.org/10.1016/j.jaci.2019.11.043.

Article  PubMed  Google Scholar 

Kempkes RWM, Joosten I, Koenen HJPM, He X. Metabolic pathways involved in regulatory T cell functionality. Front Immunol. 2019;3(10):2839. https://doi.org/10.3389/fimmu.2019.02839.

Article  Google Scholar 

Khan MM, Kalim UU, Khan MH, Lahesmaa R. PP2A and its inhibitors in helper T-cell differentiation and autoimmunity. Front Immunol. 2022;5(12):786857. https://doi.org/10.3389/fimmu.2021.786857.

Article  Google Scholar 

Gianchecchi E, Fierabracci A. Inhibitory receptors and pathways of lymphocytes: the role of PD-1 in treg development and their involvement in autoimmunity onset and cancer progression. Front Immunol. 2018;17(9):2374. https://doi.org/10.3389/fimmu.2018.02374.

Article  Google Scholar 

Chi H. Regulation and function of mTOR signalling in T cell fate decisions. Nat Rev Immunol. 2012;12(5):325–38. https://doi.org/10.1038/nri3198.

Article  PubMed  PubMed Central  Google Scholar 

Procaccini C, De Rosa V, Galgani M, Abanni L, Calì G, Porcellini A, Carbone F, Fontana S, Horvath TL, La Cava A, Matarese G. An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness. Immunity. 2010;33(6):929–41. https://doi.org/10.1016/j.immuni.2010.11.024.

Article  PubMed  PubMed Central  Google Scholar 

Stathopoulou C, Gangaplara A, Mallett G, Flomerfelt FA, Liniany LP, Knight D, Samsel LA, Berlinguer-Palmini R, Yim JJ, Felizardo TC, Eckhaus MA, Edgington-Mitchell L, Martinez-Fabregas J, Zhu J, Fowler DH, van Kasteren SI, Laurence A, Bogyo M, Watts C, Shevach EM, Amarnath S. PD-1 inhibitory receptor downregulates asparaginyl endopeptidase and maintains Foxp3 transcription factor stability in induced regulatory T cells. Immunity. 2018;49(2):247-263.e7. https://doi.org/10.1016/j.immuni.2018.05.006.

Article  PubMed  PubMed Central  Google Scholar 

Blank C, Brown I, Marks R, Nishimura H, Honjo T, Gajewski TF. Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells. J Immunol. 2003;171(9):4574–81. https://doi.org/10.4049/jimmunol.171.9.4574.

Article  PubMed  Google Scholar 

Xie Y, Lei X, Zhao G, Guo R, Cui N. mTOR in programmed cell death and its therapeutic implications. Cytokine Growth Factor Rev. 2023;71–72:66–81. https://doi.org/10.1016/j.cytogfr.2023.06.002.

Article  PubMed  Google Scholar 

Wong M, La Cava A, Hahn BH. Blockade of programmed death-1 in young (New Zealand Black x New Zealand White)F1 mice promotes the suppressive capacity of CD4+ regulatory T cells protecting from lupus-like disease. J Immunol. 2013;190(11):5402–10. https://doi.org/10.4049/jimmunol.1202382.

Article  PubMed  Google Scholar 

Apostolidis SA, Rodríguez-Rodríguez N, Suárez-Fueyo A, Dioufa N, Ozcan E, Crispín JC, Tsokos MG, Tsokos GC. Phosphatase PP2A is requisite for the function of regulatory T cells. Nat Immunol. 2016;5:556–64. https://doi.org/10.1038/ni.3390.

Article  Google Scholar 

Tai X, Van Laethem F, Pobezinsky L, Guinter T, Sharrow SO, Adams A, Granger L, Kruhlak M, Lindsten T, Thompson CB, Feigenbaum L, Singer A. Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Blood. 2012;119(22):5155–63. https://doi.org/10.1182/blood-2011-11-388918.

Article  PubMed  PubMed Central  Google Scholar 

Bai A, Guo Y. Acid sphingomyelinase mediates human CD4+ T-cell signaling: potential roles in T-cell responses and diseases. Cell Death Dis. 2017;8(7):e2963. https://doi.org/10.1038/cddis.2017.360.

Article  MathSciNet  PubMed  PubMed Central  Google Scholar 

Schildberg FA, Klein SR, Freeman GJ, Sharpe AH. Coinhibitory pathways in the B7-CD28 ligand-receptor family. Immunity. 2016;44(5):955–72. https://doi.org/10.1016/j.immuni.2016.05.002.

Article  PubMed  PubMed Central  Google Scholar 

Gabriel SS, Tsui C, Chisanga D, Weber F, Llano-León M, Gubser PM, Bartholin L, Souza-Fonseca-Guimaraes F, Huntington ND, Shi W, Utzschneider DT, Kallies A. Transforming growth factor-β-regulated mTOR activity preserves cellular metabolism to maintain long-term T cell responses in chronic infection. Immunity. 2021;54(8):1698-1714.e5. https://doi.org/10.1016/j.immuni.2021.06.007.

Article  PubMed  Google Scholar